Akebia Therapeutics Inc
SWB:AX9
Akebia Therapeutics Inc
SWB:AX9
Price:
1.07
EUR
-14.64%
Market Closed
Market Cap:
€356.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
CA |
|
S
|
State Bank of India
LSE:SBID
|
IN |
|
CCR SA
BOVESPA:CCRO3
|
BR |
|
A
|
Alpha Services and Holdings SA
XMUN:ACBB
|
GR |
|
Banco de Sabadell SA
OTC:BNDSY
|
ES |
|
Aramark
NYSE:ARMK
|
US |
|
Health Catalyst Inc
F:2YP
|
US |
|
T
|
TJX Companies Inc
F:TJX
|
US |
|
M
|
Marubeni Corp
OTC:MARUY
|
JP |
|
A
|
Addus Homecare Corp
XBER:A41
|
US |
|
Boise Cascade Co
NYSE:BCC
|
US |
|
Surgery Partners Inc
NASDAQ:SGRY
|
US |
|
E
|
Eli Lilly and Co
XETRA:LLY
|
US |
|
Inpixon
F:1XS
|
US |
|
G
|
Gilead Sciences Inc
MIL:GILD
|
US |
|
A
|
Assicurazioni Generali SpA
DUS:ASG
|
IT |
|
F
|
Funko Inc
SWB:FU2
|
US |
DCF Valuation
is not available for Akebia Therapeutics Inc
is not available for Akebia Therapeutics Inc
AX9's DCF value cannot be reliably calculated.
Switch to
Continue AX9 Research
Other Akebia Therapeutics Inc listings:
Discover More
